Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Effects of Low-dose Esmolol on Myocardial Injury After Non-cardiac Surgery in Elderly Frail Patients:A Multicenter, Prospective, Double-blind, Randomized Controlled Study
Authors not listed
Yongtao Sun · 2023
Abstract
This topic will focus on the following questions:
1. Part one: To clarify the relationship between preoperative frailty and myocardial injury (cTnT ≥0.03) after non-cardiac surgery in elderly patients; To further explore the predictive factors of myocardial injury after non-cardiac surgery (MINS) in elderly frail patients before operation.
2. Part Two: To explore the effect of low-dose esmolol on myocardial injury after non-cardiac surgery in frail elderly patients.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-23 MST
Cite this
APA
Anonymous. (2023). Effects of Low-dose Esmolol on Myocardial Injury After Non-cardiac Surgery in Elderly Frail Patients:A Multicenter, Prospective, Double-blind, Randomized Controlled Study. <em>Yongtao Sun</em>. https://clinicaltrials.gov/study/NCT05635877
Vancouver
Anonymous. Effects of Low-dose Esmolol on Myocardial Injury After Non-cardiac Surgery in Elderly Frail Patients:A Multicenter, Prospective, Double-blind, Randomized Controlled Study. Yongtao Sun. 2023.
BibTeX
@misc{anon2023Effect,
title = {Effects of Low-dose Esmolol on Myocardial Injury After Non-cardiac Surgery in Elderly Frail Patients:A Multicenter, Prospective, Double-blind, Randomized Controlled Study},
author = {Anonymous},
journal = {Yongtao Sun},
year = {2023},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Ziqiang Wang,MD 2019
Open access · US-GOV
Application of Frailty Assessment in Elderly Patients Undergoing Gastrointestinal Surgery
Eli Lilly and Company 2003
Open access · US-GOV
A Multicenter Phase 2 Randomized Trial of Single-Agent ALIMTA or ALIMTA With Sequentially Administered GEMZAR as First-Line Chemotherapy in Elderly Patients or Patients Who Are Not Eligible for Platinum-Based Chemotherapy With Advanced NSCLC
University Hospital, Lille 2000
Open access · US-GOV
Comparison of Melphalan-Prednisone(MP),MP-THALIDOMIDE,and Autologous Stem Cell Transplantation in the Treatment of Newly Diagnosed Elderly Patients With Multiple Myeloma.
Mingzhi Zhang 2024
Open access · US-GOV
A Prospective Clinical Study of the Combination Therapy of Obutinib or Decitabine with Rituximab, Cyclophosphamide, and Prednisone for the Primary Treatment of Elderly Patients with Newly Diagnosed Diffuse Large B-cell Lymphoma
SELDA MERT 2026
Open access · US-GOV
The Effect of Targeted Individualized Nursing Care Interventions on Frailty Levels and Clinical Outcomes in Frail Patients Undergoing Cardiac Surgery: A Randomized Controlled Trial
University of Chicago 2015
Open access · US-GOV